Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Dewar

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cardiovascular Research|November 1, 1982
Effect of sulphinpyrazone on the development of experimental endocardial vegetationsC E Johnson, H A Dewar
Angiologica|January 1, 1970
The lymphatic system as contributor of plasminogen activator to the bloodI S Menon, D Weightman, H A Dewar
Life Sciences|January 1, 1989
Neuropeptide Y and platelet aggregation by adrenalineH A Dewar, M A Zar, A Oxley
The Journal of the Association of Physicians of India|April 1, 1971
A comparison of blood fibrinolytic activity in children and adultsI S Menon, D Weightman, H A Dewar
British Heart Journal|May 1, 1973
Circumstances attending 100 sudden deaths in men from coronary disease by coroner's necropsiesA Myers, H A Dewar, D R Appleton
Cardiovascular Research|August 1, 1980
Fibrinolytic therapy in subacute bacterial endocarditis: an experimental studyC E Johnson, H A Dewar, W A Aherne
Age and Ageing|November 1, 1980
Beta-thromboglobulin in antecubital vein blood in relation to history of a strokeH A Dewar, T Marshall, D Weightman, et al.
Biorheology|January 1, 1970
Blood fibrinolytic activity and thermometry in patients with collagen vascular disease and response to treatmentW J Cunliffe, H A Dewar, G Holti, et al.
Atherosclerosis|July 1, 1977
Controlled trial of the effect of cycloalliin on the fibrinolytic activity of venous bloodR K Agarwal, H A Dewar, D J Newell, et al.
Neurology|October 1, 1971
Fibrinolytic activity in venous blood of patients with muscular dystrophyI S Menon, D Gardner-Medwin, D Weightman, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cardiovascular Research|November 1, 1982
Effect of sulphinpyrazone on the development of experimental endocardial vegetationsC E Johnson, H A Dewar
Angiologica|January 1, 1970
The lymphatic system as contributor of plasminogen activator to the bloodI S Menon, D Weightman, H A Dewar
Life Sciences|January 1, 1989
Neuropeptide Y and platelet aggregation by adrenalineH A Dewar, M A Zar, A Oxley
The Journal of the Association of Physicians of India|April 1, 1971
A comparison of blood fibrinolytic activity in children and adultsI S Menon, D Weightman, H A Dewar
British Heart Journal|May 1, 1973
Circumstances attending 100 sudden deaths in men from coronary disease by coroner's necropsiesA Myers, H A Dewar, D R Appleton
Cardiovascular Research|August 1, 1980
Fibrinolytic therapy in subacute bacterial endocarditis: an experimental studyC E Johnson, H A Dewar, W A Aherne
Age and Ageing|November 1, 1980
Beta-thromboglobulin in antecubital vein blood in relation to history of a strokeH A Dewar, T Marshall, D Weightman, et al.
Biorheology|January 1, 1970
Blood fibrinolytic activity and thermometry in patients with collagen vascular disease and response to treatmentW J Cunliffe, H A Dewar, G Holti, et al.
Atherosclerosis|July 1, 1977
Controlled trial of the effect of cycloalliin on the fibrinolytic activity of venous bloodR K Agarwal, H A Dewar, D J Newell, et al.
Neurology|October 1, 1971
Fibrinolytic activity in venous blood of patients with muscular dystrophyI S Menon, D Gardner-Medwin, D Weightman, et al.
Pageof 4